Related Experiment Videos
Systemic mycoses in the 21st century
1University of Texas Health Science Center at San Antonio, USA.
Infectious Disease Clinics of North America
|June 1, 1995
Summary
Systemic mycoses are increasingly significant infectious agents. Antifungal therapy is rapidly evolving, with major advancements expected in the next decade.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Systemic mycoses are emerging as significant global health threats.
- The incidence and severity of fungal infections are increasing.
- Current antifungal therapies face challenges with resistance and toxicity.
Purpose of the Study:
- To explore the rising importance of systemic mycoses.
- To review current and future roles of fungal pathogens.
- To discuss rapid advancements in antifungal drug development and therapy.
Main Methods:
- Literature review of systemic mycoses.
- Analysis of trends in antifungal therapy.
- Speculative forecast of future developments in the field.
Main Results:
- Systemic mycoses represent a growing challenge in clinical practice.
- Antifungal drug discovery and development are accelerating.
- New therapeutic strategies are emerging to combat resistant fungal strains.
Conclusions:
- The landscape of systemic mycoses and their treatment is dynamic.
- Anticipated developments promise improved management of fungal infections.
- Continued research is crucial for addressing future challenges in antifungal therapy.